在临床研究和决策模型中探索患者偏好信息:一项调查调查
Martina Di Blasio1, Zahra Bami1, Matteo Bracco1
1Center for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Patient preference and adherence
|November 19, 2025
概括
患者的偏好在医疗保健中至关重要,但其整合尚不清楚. 专家们认为,尽管存在挑战,人们越来越认识到并愿意优先考虑患者偏好信息.
科学领域:
- 医疗保健研究的研究.
- 卫生技术评估 卫生技术评估
- 患者为中心的护理
背景情况:
- 患者的偏好显著影响护理途径,质量评估和医疗保健技术的进步.
- 目前,医疗保健中患者偏好信息的使用程度在很大程度上仍未确定.
研究的目的:
- 调查医疗保健专家当前使用和未来整合患者偏好信息的情况.
- 确定与将患者偏好纳入医疗保健实践相关的挑战和机会.
主要方法:
- 对46名专家进行了在线调查.
- 受访者代表临床研究,制药行业,监管事务和医疗技术评估部门.
主要成果:
- 目前,大约30%的受访专家经常使用患者偏好信息.
- 显著多数 (90%) 表示愿意在未来优先考虑整合患者偏好信息.
- 确定的主要挑战包括患者参与度有限,数据可靠性问题以及对改变传统实践的抵抗力.
结论:
- 人们越来越认识到将患者偏好信息整合到医疗保健中的好处.
- 需要大量的努力和投资来克服障碍,并促进更广泛地采用患者偏好信息.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659
Pharmacokinetic Models: Comparison and Selection Criterion
314
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
314
Methods of Documentation VI: Case Management Model
839
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
839
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K


